NOT-DK-23-029: Notice of Change to the Letters of Intent Due Date for "RFA-DK-22-037: Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed)"

Notice of Change to the Letters of Intent Due Date for "RFA-DK-22-037: Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 – Independent Clinical Trial not Allowed)"

Notice Number:

NOT-DK-23-029

Key Dates

Release Date:

June 6, 2023

Related Announcements

February 27, 2023 - Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 – Independent Clinical Trial not Allowed). See NOFO RFA-DK-22-037.

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice corrects the Due Date for a Letter of Intent in RFA-22-037 Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 – Independent Clinical Trial not Allowed)

Part 1. Key Dates

Currently reads:

Letter of Intent Due Date(s)

January 15, 2024

Modified to read:

Letter of Intent Due Date(s)

September 25, 2023

All other aspects of this NOFO remain the same.

Inquiries

Please direct all inquiries to:

J. Rafael Gorospe, M.D., Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-2556
Email: gorospejr@mail.nih.gov